WallStreetZenWallStreetZen

NYSE: BMY
BRISTOL MYERS SQUIBB CO Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

BMY past earnings growth

How has BMY's earnings growth performed historically?
Company
N/A
Industry
97.28%
Market
92.76%
BMY's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
BMY's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

BMY past revenue growth

How has BMY's revenue growth performed historically?
Company
9.69%
Industry
24.91%
Market
51.15%
BMY's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BMY's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BMY's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BMY earnings and revenue history

Current Revenue
$47.0B
Current Earnings
$6.3B
Current Profit Margin
13.3%
BMY's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

BMY Return on Equity

Current Company
17.7%
Current Industry
42%
Current Market
38.4%
BMY's Return on Equity (17.7%)... subscribe to Premium to read more.
High Return on Equity Performance

BMY Return on Assets

Current Company
5.8%
Current Industry
10.4%
BMY is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BMY Return on Capital Employed

Current Company
9.02%
Current Industry
15.6%
BMY's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BMY vs General Drug Manufacturer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BMY$46.96B$17.84B$6.25B+18.66%-0.49%
SNY$44.52B$13.07B$7.07B+4.04%+7.95%
AMGN$26.32B$11.12B$5.72B+2.79%-0.84%
NVS$53.00B$21.86B$24.18B+1.41%+32.27%
GSK$45.60B$11.44B$6.39B+5.77%+25.68%
View Top General Drug Manufacturer Stocks

BRISTOL MYERS SQUIBB Earnings & Revenue FAQ

What were BMY's earnings last quarter?

On Invalid Date, BRISTOL MYERS SQUIBB (NYSE: BMY) reported Q1 2022 earnings per share (EPS) of $0.60, up 33.33% year over year. Total BRISTOL MYERS SQUIBB earnings for the quarter were $1.28 billion. In the same quarter last year, BRISTOL MYERS SQUIBB's earnings per share (EPS) was $0.90.

What was BMY's earnings growth in the past year?

As of Q2 2022, BRISTOL MYERS SQUIBB's earnings has grown null year over year. BRISTOL MYERS SQUIBB's earnings in the past year totalled $6.25 billion.

What was BMY's revenue last quarter?

On Invalid Date, BRISTOL MYERS SQUIBB (NYSE: BMY) reported Q1 2022 revenue of $11.65 billion up 5.19% year over year. In the same quarter last year, BRISTOL MYERS SQUIBB's revenue was $11.07 billion.

What was BMY's revenue growth in the past year?

As of Q2 2022, BRISTOL MYERS SQUIBB's revenue has grown 9.69% year over year. This is 15.21 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 24.91%. BRISTOL MYERS SQUIBB's revenue in the past year totalled $46.96 billion.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending StocksStock Market SectorsStock Market Industries
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.